CD44 Targeted Nanomaterials for Treatment of Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is one of the most challenging tumors with aggressive behavior, low recovery rate, poor prognosis, high metastatic potential, and rapid relapse compared to other breast cancer subtypes. Conventional therapies currently have minimal effect on TNBC;...

Descripción completa

Detalles Bibliográficos
Autores principales: Nabil, Ghazal, Alzhrani, Rami, Alsaab, Hashem O., Atef, Mohammed, Sau, Samaresh, Iyer, Arun K., Banna, Hossny El
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924562/
https://www.ncbi.nlm.nih.gov/pubmed/33672756
http://dx.doi.org/10.3390/cancers13040898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7924562/
https://www.ncbi.nlm.nih.gov/pubmed/33672756
http://dx.doi.org/10.3390/cancers13040898

Ejemplares similares